Zentalis Pharmaceuticals Inc

Research Zentalis Pharmaceuticals Inc (ZNTL) on Bullrun: market cap USD 328.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerZNTL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 328.17M
• Financial periodFY2025
• Revenue growth-100.0%
• Net income-USD 137.06M
• Free cash flow-USD 125.25M

Valuation Snapshot

latest market cap is USD 328.17M.

About Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors;

Frequently asked questions

What is Zentalis Pharmaceuticals Inc's market cap?

Zentalis Pharmaceuticals Inc's market capitalization is USD 328.17M.

What does Zentalis Pharmaceuticals Inc do?

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.